Showing results (211-220 of 2,971) with videos related to
Sort By:
Pageof 298
Neuropeptides|February 5, 2000
Further pharmacological characterization of the selective melanocortin 4 receptor antagonist HS014: comparison with SHU9119H B Schiöth, R Muceniece, F Mutulis, et al.Neuropeptides|February 5, 2000
Pharmacological characterization of mucin secretion from CHO-K1-hNK(1)R cellsR Caccese, A Graham, R BialeckiNeuropeptides|February 5, 2000
Vascular neuropeptide Y Y1-receptors in the rat kidney: vasoconstrictor effects and expression of Y1-receptor mRNAA Modin, R E Malmström, B MeisterNeuropeptides|February 5, 2000
Chromogranin A in the central nervous system of the rat: pan-neuronal expression of its mRNA and selective expression of the proteinJ Woulfe, D Deng, D MunozNeuropeptides|February 5, 2000
Cholecystokinin: proofs and prospects for involvement in control of food intake and body weightR C Ritter, M Covasa, C A MatsonNeuropeptides|February 5, 2000
Changes of environment and darkness enhance the NADPH-diaphorase staining in the rat paraventricular nucleusF Sánchez, M J López, J del Campo, et al.Neuropeptides|February 5, 2000
A radioiodinated 7alpha-O-iodoallyl diprenorphine for mapping opioid receptorsR F Wang, J A Tafani, J M Zajac, et al.Neuropeptides|February 5, 2000
Thyrotropin-releasing hormone-induced GH release after cocaine withdrawal in cocaine addictsP P Vescovi, A PezzarossaNeuropeptides|February 5, 2000
Differential modulation by baclofen on antinociception induced by morphine and beta-endorphin administered intracerebroventricularly in the formalin testK M Chung, Y H Kim, D K Song, et al.Neuropeptides|April 2, 1999
Immunomodulatory action of class mu-, delta- and kappa-opioid receptor agonists in miceJ KowalskiPageof 298